SCHEMBL32688016

SCHEMBL32688016

COc1ccc(NC(=O)c2cccc(-c3cc(=O)[nH]c(SCc4nnn[nH]4)c3C#N)c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KISS1R Q969F8 3/20 0.42
▸ POLB P06746 2/20 0.40
▸ MAPT P10636 2/20 0.40
▸ MET P08581 1/20 0.40
▸ KDR P35968 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ SIRT2 Q8IXJ6 1/20 0.40
▸ KLK7 P49862 1/20 0.40
▸ MAPK14 Q16539 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ PKM P14618 1/20 0.39
▸ LOX P28300 1/20 0.39
▸ LOXL2 Q9Y4K0 1/20 0.39
▸ LDHA P00338 1/20 0.38
▸ LDHB P07195 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ PLAU P00749 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688221 0.91 SIRT2 (0.46) POLBMAPTMETKDRKMT2A
SCHEMBL32688271 0.91 ALDH1A1 (0.42) KISS1RPOLBMAPTMETKDR
SCHEMBL32688254 0.88 UGCG (0.40) POLBMAPTKMT2ASIRT2
SCHEMBL32688358 0.85 PSMD14 (0.43) POLBMETKDRALDH1A1SIRT2
SCHEMBL32688149 0.85 TNKS2 (0.40) KISS1RPOLBMAPTALDH1A1KMT2A
SCHEMBL32688247 0.83 ACMSD (0.44) ALDH1A1KMT2A
SCHEMBL32688056 0.82 MET (0.41) POLBMAPTMETKDRALDH1A1
SCHEMBL32688014 0.82 ULK1 (0.38) KISS1RPOLBMAPTALDH1A1KMT2A
SCHEMBL32688196 0.82 MAPK14 (0.38) ALDH1A1KMT2AMAPK14
SCHEMBL32688038 0.82 ACMSD (0.45) POLBMAPTALDH1A1KMT2APKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK KISS1R 3968/4885POLB 508/4885MAPT 4018/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback